Research

Energy balance

Significant disproportionality was detected for semaglutide-associated suicidal ideation (ROR, 1.45; 95% CI, 1.18-1.77; IC, 0.53; 95% CI, 0.19-0.78).

Clinicians should be aware of the potential risk of suicidal ideation in patients treated with semaglutide.

StrongSupportsmedium confidence
Significant disproportionality was detected only for semaglutide-associated suicidal ideation (ROR, 1.45; 95% CI, 1.18-1.77; IC, 0.53; 95% CI, 0.19-0.78).
Georgios Schoretsanitis et al. · JAMA Network Open · 2024

Why this rating

Based on the disproportionality analysis using WHO data.

Source

Disproportionality Analysis From World Health Organization Data on Semaglutide, Liraglutide, and Suicidality

Georgios Schoretsanitis et al. · JAMA Network Open · 2024

DOI 10.1001/jamanetworkopen.2024.23385

other · n=269Cited 86×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →